Literature DB >> 18351206

Sandwich bone augmentation using recombinant human platelet-derived growth factor and beta-tricalcium phosphate alloplast: case report.

Ho-Young Byun1, Horn-Lay Wang.   

Abstract

This report presents a case of reconstructing and augmenting a buccal fenestration defect associated with simultaneous implant placement using recombinant human platelet-derived growth factor BB (rhPDGF-BB) combined with the synthetic alloplast beta-tricalcium phosphate (beta-TCP) and collagen membrane. Fenestration and fracture of the labial plate occurred at the time of implant placement at the maxillary left lateral incisor position. The sandwich bone augmentation technique was applied using autogenous bone as the inner grafting material and rhPDGF-BB + beta-TCP as the outer grafting material. A collagen barrier membrane was then tented over these materials. After approximately 5 months of healing, second-stage surgery was performed, showing complete healing at the defect site. This case suggests that the combination of rhPDGF-BB and beta-TCP can be a suitable material for predictable bone augmentation, especially during sandwich bone augmentation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18351206

Source DB:  PubMed          Journal:  Int J Periodontics Restorative Dent        ISSN: 0198-7569            Impact factor:   1.840


  3 in total

1.  Bone cement grafting increases implant primary stability in circumferential cortical bone defects.

Authors:  Seung-Yun Shin; Seung-Il Shin; Seung-Beom Kye; Seok-Woo Chang; Jongrak Hong; Jun-Young Paeng; Seung-Min Yang
Journal:  J Periodontal Implant Sci       Date:  2015-02-25       Impact factor: 2.614

2.  Ridge augmentation in implant dentistry.

Authors:  Young-Kyun Kim; Jeong-Kui Ku
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2020-06-30

3.  Surgical Approaches Based on Biological Objectives: GTR versus GBR Techniques.

Authors:  Gaia Pellegrini; Giorgio Pagni; Giulio Rasperini
Journal:  Int J Dent       Date:  2013-06-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.